Category

Blastoma

More Children With High-Risk Brain Cancer Now Surviving Blastoma

More Children With High-Risk Brain Cancer Now Surviving

A practice-changing study that used molecular testing to distinguish between subtypes of medulloblastoma has shown a significant improvement in survival for children with high-risk disease who underwent treatment intensification with carboplatin. "Each of the four subgroups of medulloblastoma has a different prognosis, but for this particular subgroup, 20 fewer children…
bubmag
July 26, 2021
Investigational magnetic device shrinks glioblastoma in first-in-world human test Blastoma

Investigational magnetic device shrinks glioblastoma in first-in-world human test

Device helmet with 3 oncoscillators securely attached. The oncoscillators are connected to a controller box powered by a rechargeable battery. Credit: Houston Methodist Houston Methodist Neurological Institute researchers from the department of neurosurgery shrunk a deadly glioblastoma tumor by more than a third using a helmet generating a noninvasive oscillating…
bubmag
July 22, 2021
Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network Blastoma

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network

IMAGE: EGCG maintains neuronal cell cytoskeleton integrity. Methyl glyoxal treatment leads to glycation of actin and microtubules leading to hampered growth of neuritic extensions and microtubule organization. Microtubule stabilization by +TIP... view more  Credit: Correspondence to - Subashchandrabose Chinnathambi - s.chinnathambi@ncl.res.in Oncotarget published "Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network"…
bubmag
July 12, 2021
Oncotarget: Genome wide DNA methylation landscape reveals glioblastoma’s influence Blastoma

Oncotarget: Genome wide DNA methylation landscape reveals glioblastoma’s influence

IMAGE: Expression pattern of ligands of corresponding receptors specific for CD4+ T cell lineages in GBM tumor tissue. (A-D) The heatmaps show expression of the ligands in tumor tissue and graphical... view more  Credit: Correspondence to - Mahua Dey - dey@neurosurgery.wisc.edu Oncotarget published "Genome wide DNA methylation landscape reveals glioblastoma's influence…
bubmag
July 5, 2021
The Cancer Custodians Blastoma

The Cancer Custodians

Part of Dennis Plenker’s daily job is growing cancer. And a variety of different ones, too. Depending on the day and the project, different tumors may burgeon in the petri dishes stocked in the Cold Spring Harbor Laboratory where Plenker works as a research investigator. They might be aggressive breast…
bubmag
June 23, 2021
Limited edition bracelet to help little warriors fighting rare childhood cancer Blastoma

Limited edition bracelet to help little warriors fighting rare childhood cancer

South of the River, a small fashion boutique based in Beckenham, Kent, is supporting Neuroblastoma UK, a national children’s cancer charity this summer with a limited edition ‘Warrior’ Tile Bracelet. Inspired by children with cancer and designed in collaboration with Neuroblastoma UK, each bracelet features white ‘Warrior’ tiles on a…
bubmag
June 1, 2021
Oncotarget: Piperlongumine promotes death of retinoblastoma cancer cells Blastoma

Oncotarget: Piperlongumine promotes death of retinoblastoma cancer cells

IMAGE: Effects of PL on cell cycle-regulatory factors in WERI-Rb and Y79 cells. (A) The expression of CDC25C, CDK1, CCNA2, CCNB1, CDKN1A and CDKN1B was measured at mRNA levels using real... view more  Credit: Correspondence to - Nathalie Allaman-Pillet - nathalie.allaman@gmail.com Oncotarget published "Piperlongumine promotes death of retinoblastoma cancer cells" which…
bubmag
May 31, 2021
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications Blastoma

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications

Home Press release May 07, 2021 11:08 JST Source: Eisai Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications For Advanced Renal Cell Carcinoma and for Advanced Endometrial CarcinomaApplications Based on Progression-Free Survival, Overall Survival, and Objective Response…
bubmag
May 7, 2021